cognitive impairment

Prognostic value of GFAP and UCHL-1 biomarkers in high-risk mild traumatic brain injury: A prospective longitudinal study of short- and long-term outcomes

Study Overview The research focused on evaluating the prognostic significance of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase […]

Prognostic value of GFAP and UCHL-1 biomarkers in high-risk mild traumatic brain injury: A prospective longitudinal study of short- and long-term outcomes Read Post »

The biomarker and clinical changes across the Alzheimer’s continuum study (BCAS): rationale, design, and baseline characteristics of the first 1,013 participants

Study Overview The BCAS study focuses on understanding the progression of Alzheimer’s disease through a comprehensive exploration of biomarker and

The biomarker and clinical changes across the Alzheimer’s continuum study (BCAS): rationale, design, and baseline characteristics of the first 1,013 participants Read Post »

Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial

Study Overview The recent multicentre, randomised, double-blind, phase 3 clinical trial investigated the efficacy and safety of L-oxiracetam in enhancing

Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial Read Post »

Scroll to Top